1887

Abstract

The neutralizing activity of anti-hepatitis C virus (HCV) antibodies is attenuated by a factor present in human sera, which has been proposed to be high-density lipoproteins (HDLs). HDLs have also been shown to facilitate the entry of HCV pseudoparticles (HCVpp) into target cells. Here, the aim of the study was to determine whether HDL-mediated facilitation of HCVpp and infectious HCV (HCVcc) entry and attenuation of neutralization are two related phenomena. The data indicated that HDLs attenuate neutralization at a constant rate. In addition, as for HDL-mediated facilitation of HCVpp entry, attenuation of neutralization depended on the expression of the scavenger receptor BI (SR-BI) and its selective lipid-uptake function. Finally, kinetic experiments showed that HDL-mediated facilitation of HCVpp entry is more rapid than virus neutralization. Altogether, these observations indicate that HCV is exploiting the physiological activity of SR-BI for promoting its entry into target cells, which consequently also protects the virus against neutralizing antibodies.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81932-0
2006-09-01
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/9/2577.html?itemId=/content/journal/jgv/10.1099/vir.0.81932-0&mimeType=html&fmt=ahah

References

  1. Bartosch, B., Bukh, J., Meunier, J.-C., Granier, C., Engle, R. E., Blackwelder, W. C., Emerson, S. U., Cosset, F.-L. & Purcell, R. H. ( 2003a; ). In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 100, 14199–14204.[CrossRef]
    [Google Scholar]
  2. Bartosch, B., Dubuisson, J. & Cosset, F.-L. ( 2003b; ). Infectious hepatitis C virus pseudo-particles containing functional E1–E2 envelope protein complexes. J Exp Med 197, 633–642.[CrossRef]
    [Google Scholar]
  3. Bartosch, B., Verney, G., Dreux, M., Donot, P., Morice, Y., Penin, F., Pawlotsky, J.-M., Lavillette, D. & Cosset, F.-L. ( 2005; ). An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 79, 8217–8229.[CrossRef]
    [Google Scholar]
  4. Drummer, H. E., Maerz, A. & Poumbourios, P. ( 2003; ). Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 546, 385–390.[CrossRef]
    [Google Scholar]
  5. Hatch, F. T. ( 1968; ). Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6, 1–68.
    [Google Scholar]
  6. Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M. & McKeating, J. A. ( 2003; ). Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100, 7271–7276.[CrossRef]
    [Google Scholar]
  7. Huang, Z. H., Gu, D., Lange, Y. & Mazzone, T. ( 2003; ). Expression of scavenger receptor BI facilitates sterol movement between the plasma membrane and the endoplasmic reticulum in macrophages. Biochemistry 42, 3949–3955.[CrossRef]
    [Google Scholar]
  8. Lavillette, D., Morice, Y., Germanidis, G. & 8 other authors ( 2005a; ). Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 79, 6023–6034.[CrossRef]
    [Google Scholar]
  9. Lavillette, D., Tarr, A. W., Voisset, C. & 7 other authors ( 2005b; ). Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41, 265–274.[CrossRef]
    [Google Scholar]
  10. Logvinoff, C., Major, M. E., Oldach, D. & 7 other authors ( 2004; ). Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A 101, 10149–10154.[CrossRef]
    [Google Scholar]
  11. Meunier, J.-C., Engle, R. E., Faulk, K. & 7 other authors ( 2005; ). Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 102, 4560–4565.[CrossRef]
    [Google Scholar]
  12. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T. & Sato, J. ( 1982; ). Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42, 3858–3863.
    [Google Scholar]
  13. Nieland, T. J. F., Penman, M., Dori, L., Krieger, M. & Kirchhausen, T. ( 2002; ). Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc Natl Acad Sci U S A 99, 15422–15427.[CrossRef]
    [Google Scholar]
  14. Peng, Y., Akmentin, W., Connelly, M. A., Lund-Katz, S., Phillips, M. C. & Williams, D. L. ( 2004; ). Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. Mol Biol Cell 15, 384–396.
    [Google Scholar]
  15. Rhainds, D. & Brissette, L. ( 2004; ). The role of scavenger receptor class B type I (SR-BI) in lipid trafficking: defining the rules for lipid traders. Int J Biochem Cell Biol 36, 39–77.[CrossRef]
    [Google Scholar]
  16. Rouillé, Y., Helle, F., Delgrange, D. & 10 other authors ( 2006; ). Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80, 2832–2841.[CrossRef]
    [Google Scholar]
  17. Voisset, C., Callens, N., Blanchard, E., Op De Beeck, A., Dubuisson, J. & Vu-Dac, N. ( 2005; ). High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280, 7793–7799.[CrossRef]
    [Google Scholar]
  18. Wakita, T., Pietschmann, T., Kato, T. & 9 other authors ( 2005; ). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791–796.[CrossRef]
    [Google Scholar]
  19. Yu, M. Y. W., Bartosch, B., Zhang, P. & 7 other authors ( 2004; ). Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. Proc Natl Acad Sci U S A 101, 7705–7710.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81932-0
Loading
/content/journal/jgv/10.1099/vir.0.81932-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error